Estados financieros detallados de Syndax Pharmaceuticals, Inc. (SNDX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Syndax Pharmaceuticals, Inc. registró ingresos de $172.4M en el último ejercicio fiscal, con un CAGR de 5 años del 157.7%.
Márgenes de los últimos 12 meses: margen bruto 97.5%, margen operativo -77.1%, margen neto -87.6%.
Al precio actual de $17.28, SNDX presenta beneficios negativos (P/E no significativo) y un ROE del -372.94%. La capitalización bursátil es de $1.5B.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.2M | $2.1M | $1.5M | $1.5M | $1.5M | $139.7M | 0 | 0 | $23.7M | $172.4M |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $826000 | $7.0M |
| Beneficio Bruto | $1.2M | $2.1M | $1.5M | $1.5M | $1.5M | $139.7M | 0 | 0 | $22.9M | $165.4M |
| I+D | $31.7M | $48.2M | $60.1M | $43.0M | $50.4M | $88.2M | $118.5M | $163.0M | $241.6M | $258.8M |
| Generales y Administrativos | $13.3M | $15.9M | $17.3M | $16.1M | $22.5M | $25.2M | $33.3M | $66.9M | $120.9M | $179.7M |
| Gastos Operativos | $45.0M | $64.1M | $77.4M | $59.1M | $72.9M | $113.5M | $151.8M | $230.0M | $362.5M | $438.5M |
| Beneficio Operativo | -$43.8M | -$62.0M | -$75.9M | -$57.5M | -$71.4M | $26.2M | -$151.8M | -$230.0M | -$339.7M | -$273.1M |
| EBITDA | -$43.7M | -$61.9M | -$73.9M | -$55.6M | -$70.3M | $26.9M | -$146.2M | -$209.1M | -$313.8M | -$251.6M |
| Gastos por Intereses | $956000 | $1.4M | $1.9M | 0 | $2.4M | $1.9M | $3.1M | $208000 | $4.9M | $33.8M |
| Beneficio Antes de Impuestos | -$44.5M | -$60.8M | -$74.0M | -$56.0M | -$73.2M | $24.9M | -$149.3M | -$209.4M | -$318.8M | -$285.4M |
| Impuestos | -$89000 | -$76000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$44.5M | -$60.8M | -$74.0M | -$56.0M | -$73.1M | $24.9M | -$149.3M | -$209.4M | -$318.8M | -$285.4M |
| BPA | $-3.04 | $-2.90 | $-2.92 | $-1.84 | $-1.77 | $0.48 | $-2.46 | $-2.98 | $-3.73 | $-3.29 |
| BPA Diluido | $-3.04 | $-2.90 | $-2.92 | $-1.84 | $-1.77 | $0.48 | $-2.46 | $-2.98 | $-3.73 | $-3.29 |
| Acciones en Circulación (Diluidas) | $14.6M | $21.0M | $25.4M | $30.5M | $41.3M | $52.1M | $60.8M | $70.4M | $85.6M | $86.6M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $23.8M | $35.2M | $33.8M | $24.6M | $115.2M | $222.0M | $74.4M | $295.4M | $154.1M | $134.9M |
| Inversiones a Corto | $81.5M | $94.8M | $47.1M | $35.2M | $177.8M | $224.9M | $410.0M | $282.2M | $428.8M | $278.8M |
| Cuentas por Cobrar | $306000 | $377000 | $253000 | $116000 | $175000 | $429000 | $4.1M | $1.2M | $13.9M | $70.3M |
| Inventario | $2.4M | -$1.4M | $1.1M | 0 | 0 | 0 | 0 | 0 | $366000 | $32.8M |
| Activos Corrientes | $108.5M | $133.4M | $83.3M | $62.3M | $298.9M | $448.4M | $489.8M | $580.9M | $603.1M | $528.1M |
| Inmovilizado Material | $260000 | $267000 | $373000 | $997000 | $482000 | $1.3M | $1.1M | $1.5M | $2.0M | $1.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $109.0M | $137.2M | $83.9M | $63.5M | $300.6M | $449.7M | $497.2M | $612.9M | $724.8M | $529.7M |
| Cuentas por Pagar | $2.4M | $2.2M | $1.4M | $6.2M | $3.5M | $5.7M | $4.3M | $10.0M | $11.6M | $16.6M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $2.3M | 0 | 0 | 0 | $12.1M | 0 |
| Pasivos Corrientes | $10.4M | $15.8M | $16.1M | $18.4M | $18.9M | $20.7M | $29.1M | $58.1M | $103.5M | $120.1M |
| Deuda a Largo | 0 | 0 | 0 | 0 | $17.8M | $19.9M | 0 | 0 | $331.6M | $345.0M |
| Pasivos Totales | $24.9M | $32.9M | $30.9M | $31.9M | $48.4M | $41.3M | $29.8M | $58.7M | $436.7M | $465.1M |
| Reservas | -$305.3M | -$366.1M | -$439.4M | -$495.5M | -$568.6M | -$543.7M | -$693.0M | -$902.4M | -$1.22B | -$1.51B |
| Patrimonio Neto | $84.1M | $104.3M | $53.0M | $31.6M | $252.2M | $408.4M | $467.4M | $554.2M | $288.1M | $64.6M |
| Deuda Total | 0 | 0 | 0 | $897000 | $20.5M | $21.0M | $1.2M | $1.6M | $345.7M | $346.5M |
| Deuda Neta | -$105.3M | -$133.2M | -$80.9M | -$58.9M | -$272.5M | -$425.9M | -$483.2M | -$575.9M | -$237.2M | -$67.2M |
| Capital Circulante | $98.1M | $117.6M | $67.2M | $44.0M | $280.0M | $427.7M | $460.7M | $522.8M | $499.5M | $408.0M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$44.5M | -$60.8M | -$74.0M | -$56.0M | -$73.2M | $24.9M | -$149.3M | -$209.4M | -$318.8M | -$285.4M |
| Amortizaciones | $89000 | $76000 | $78000 | $92000 | $89000 | $43000 | $33000 | $12000 | $8000 | $6000 |
| Compensación en Acciones | $4.7M | $5.5M | $6.2M | $6.0M | $9.1M | $13.3M | $16.0M | $31.0M | $43.0M | $47.5M |
| Cambio en Capital Circulante | $2.9M | $7.7M | -$302000 | -$241000 | -$7.9M | -$9.6M | $1.7M | $31.9M | $13.3M | -$79.3M |
| Flujo de Caja Operativo | -$35.2M | -$47.4M | -$68.5M | -$50.6M | -$71.3M | $29.1M | -$133.7M | -$160.6M | -$274.9M | -$323.0M |
| Inversiones (CapEx) | -$261000 | -$84000 | -$187000 | 0 | 0 | -$129000 | -$225000 | 0 | 0 | -$187000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | $40744 | $225000 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | -$2.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$35.4M | -$47.5M | -$68.7M | -$50.6M | -$71.3M | $29.0M | -$133.9M | -$160.6M | -$274.9M | -$323.2M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +72.8% | -28.0% | +0.0% | +0.0% | +9109.6% | -100.0% | +627.8% | |||
| Crecimiento Beneficio Neto (anual) | -36.7% | -21.6% | +24.3% | -30.6% | +134.1% | -699.1% | -40.2% | -52.3% | +10.5% | |
| Crecimiento BPA (anual) | +4.6% | -0.7% | +37.0% | +3.8% | +127.1% | -612.5% | -21.1% | -25.2% | +11.8% | |
| Cambio en Acciones (anual) | +43.6% | +20.8% | +20.2% | +35.5% | +26.0% | +16.7% | +15.8% | +21.7% | +1.2% | |
| Crecimiento FCF (anual) | -34.0% | -44.8% | +26.3% | -40.8% | +140.7% | -561.7% | -19.9% | -71.2% | -17.6% | |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 96.5% | 96.0% | ||
| Margen Operativo | -3587.4% | -2939.0% | -5001.7% | -3792.9% | -4708.2% | 18.8% | -1434.4% | -158.4% | ||
| Margen EBITDA | -3580.1% | -2935.4% | -4870.3% | -3664.9% | -4633.2% | 19.2% | -1325.3% | -146.0% | ||
| Margen Neto | -3645.2% | -2884.3% | -4875.5% | -3688.5% | -4816.7% | 17.8% | -1346.1% | -165.6% | ||
| Margen FCF | -2903.1% | -2251.2% | -4529.9% | -3336.3% | -4697.4% | 20.8% | -1160.9% | -187.5% | ||
| Tasa Impositiva Efectiva | 0.2% | 0.1% | -0.0% | -0.0% | -0.0% | 0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-2.42 | $-2.26 | $-2.71 | $-1.66 | $-1.73 | $0.56 | $-2.20 | $-2.28 | $-3.21 | $-3.73 |
| Dividendo por Acción | $0.18 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $14.6M | $21.0M | $25.4M | $30.5M | $41.3M | $52.1M | $60.8M | $70.4M | $85.6M | $86.6M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -372.94% |
| Rentabilidad sobre capital invertido | -32.10% |
| Rentabilidad sobre activos | -31.37% |
| Margen bruto | 97.47% |
| Margen operativo | -77.05% |
| Margen neto | -87.60% |
Salud financiera
| Deuda / Patrimonio | 39.03 |
| Ratio corriente | 6.77 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -2.36 | -3.02 | -1.52 | -4.77 | -12.56 | 45.60 | -10.35 | -7.25 | -3.54 | -6.39 |
| P/VC | 1.25 | 1.76 | 2.13 | 8.47 | 3.64 | 2.79 | 3.31 | 2.74 | 3.93 | 28.16 |
| P/V | 85.92 | 87.26 | 74.43 | 176.47 | 605.60 | 8.16 | 0.00 | 0.00 | 47.80 | 10.56 |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% | 0.0% | 96.5% | 96.0% |
| Margen Operativo | -3587.4% | -2939.0% | -5001.7% | -3792.9% | -4708.2% | 18.8% | 0.0% | 0.0% | -1434.4% | -158.4% |
| Margen Neto | -3645.2% | -2884.3% | -4875.5% | -3688.5% | -4816.7% | 17.8% | 0.0% | 0.0% | -1346.1% | -165.6% |
Empresas relacionadas: AMLX · ATAI · CVAC · IMTX · INBX · NKTR · ORIC
Explorar sector: Healthcare · Biotechnology
Más secciones de SNDX: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones